Background: Burkitt lymphoma, is described as an aggressive form of non-Hodgkin lymphoma of B cells which occurs most often in children and young adults, ovarian lymphoma can appear as a primary lesion or more commonly referred to as a metastasis. Primary ovarian lesions are rare manifestations corresponding to 0.5% of non-Hodgkin lymphoma and 1.5% of ovarian tumors. Clinic case: 31 years old female with general weakness, march incapacity, dyspnea, hyporexia, fever, diaphoresis, weight loss of 20 kg, flat abs with abdominal pain; Ca125 610 U/ml. Abdominal computed tomography shows a solid aspect tumor which affects the right pelvic cavity. Bilateral ovarian tumors were removed. Microscopically, both lesions show a "starry sky" pattern composed by a monotonous infiltration of lymphocytes mixed with large and clear macrophages, several atypical mitoses, and necrosis and hemorrhage areas. Immunohistochemistry was positive for CD10, CD20, and negative for CD3 and high Ki67 proliferation index. Bilateral ovarian Burkitt's lymphoma was diagnosed.

Conclusion: Bilateral ovarian Burkitt's lymphoma is a rare entity, with a variability of presentations, the abdominal pain and abdominal tumors are the most frequent. The patient's prognosis at short term is poor, therefore it's necessary to know this entity and make an early diagnosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ovarian burkitt's
12
burkitt's lymphoma
12
bilateral ovarian
12
non-hodgkin lymphoma
8
ovarian tumors
8
abdominal pain
8
lymphoma
7
ovarian
6
[bilateral ovarian
4
lymphoma case
4

Similar Publications

Article Synopsis
  • Vaginal natural orifice transluminal endoscopic surgery (vNOTES) is a new surgical method that combines vaginal access with laparoscopic tools, resulting in less postoperative pain and shorter hospital stays due to no abdominal incisions.
  • Ovarian tissue cryopreservation is a technique to safeguard the reproductive health of young women at risk of premature ovarian insufficiency from cancer treatments, involving the removal and freezing of ovarian tissue for future transplant after cancer remission.
  • This study details the use of vNOTES for performing ovarian biopsies for cryopreservation, although the technique has not yet been applied for this purpose in clinical practice.
View Article and Find Full Text PDF

Ovarian tissue cryopreservation (OTC) and subsequent transplantation (OTT) is a fertility preservation technique widely offered to prepubertal girls and young fertile women who need to undergo oncological treatment but are at a high risk of infertility. However, OTT is not considered safe in patients with certain diseases like leukemia, Burkitt's lymphoma, and ovarian cancer because of the associated risk of malignant cell reintroduction. In vitro follicle development has therefore emerged as a promising means of obtaining mature metaphase II (MII) oocytes from the primordial follicle (PMF) pool contained within cryopreserved ovarian tissue, without the need for transplantation.

View Article and Find Full Text PDF

Primary Ovarian Burkitts Lymphoma.

J Ayub Med Coll Abbottabad

February 2024

Gynae B Unit, Hayatabad Medical Complex, Peshawar, Pakistan.

Primary ovarian Burkitt lymphoma (BL) is a very rare and aggressive malignancy. We report an 18-year-old female patient who presented with a large, tender abdomen, and highly de-ranged renal and liver functions. Ultrasonography showed hepatosplenomegaly, mild ascites, dilated biliary channels and a heterogeneous pelvic mass of size ~15106.

View Article and Find Full Text PDF

The amount of unfolded proteins is increased in cancer cells, leading to endoplasmic reticulum (ER) stress. Therefore, cancer cells are sensitive to drugs capable of further enhancing ER stress. Examples of such drugs include the clinically approved proteosome inhibitors bortezomib and carfilzomib.

View Article and Find Full Text PDF

Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood, arising from the bone marrow. ALL may present at diagnosis or relapse at extramedullary sites. In recent years, autologous T-cells engineered to express a chimeric-antigen receptor (CAR-T cells) have emerged as novel immune-based therapies for relapsed and refractory ALL, targeting the B-cell surface antigen CD19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!